Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures
Liver International · 2026
DOI: 10.1111/liv.70865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Antonia Gillmeister und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine I, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden (TUD), Dresden, Germany. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Bile Duct Neoplasms, Cholangiocarcinoma, Cholestasis. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The differentiation between benign and malignant biliary strictures remains a significant clinical challenge. Recent studies have suggested that next generation sequencing (NGS) can improve the diagnostic accuracy. However, evidence on its performance in routine clinical practice is limited. Therefore, validation of the diagnostic value of NGS using real‐world clinical data is warranted. We compared the performance of NGS analysis of cholangiocellular carcinoma (CCC)‐associated mutations in endoscopic biopsies with that of histopathology, CA19‐9 and cross‐sectional imaging. NGS showed higher sensitivity for malignancy (65%) compared to histopathology (52%) at similar specificity (96% vs. 100%). The combination of NGS and histopathology further increased sensitivity for malignancy to 78% ( p = 0.03) at similar specificity (96%). Our data provide support for the use of NGS in the diagnostic workup of biliary strictures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine I, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden (TUD), Dresden, Germany.
- Institute for Pathology, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden (TUD), Dresden, Germany.
- Department of Visceral Surgery and Medicine, Inselspital - Bern University Hospital, University of Bern, Bern, Switzerland.
ORCID-Profile: Antonia Gillmeister, Jochen Hampe
Zitieren
APA
Gillmeister, A., Husman, J., Schmelz, R., Brückner, S., Hampe, J., Aust, D., & Zeissig, S. (2026). Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures. Liver International. https://doi.org/10.1111/liv.70865
Vancouver
Gillmeister A, Husman J, Schmelz R, Brückner S, Hampe J, Aust D, et al. Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures. Liver International. 2026. doi:10.1111/liv.70865
BibTeX
@article{Gillmeister2026,
author = {Gillmeister, Antonia and Husman, Julia and Schmelz, Renate and Brückner, Stefan and Hampe, Jochen and Aust, Daniela and Zeissig, Sebastian},
title = {Next Generation Sequencing for the Differentiation of Benign and Malignant Biliary Strictures},
journal = {Liver International},
year = {2026},
doi = {10.1111/liv.70865}
}
EUVIMED